Proof-of-concept exploit code has been published for a critical remote code execution flaw in protobuf.js, a widely used ...

Opening statements are set for Tuesday in Harvey Weinstein’s third trial on a New York rape charge. Four days of jury ...

President Donald Trump will give an update on the Iran war on Wednesday, April 1, according to White House Press Secretary Karoline Leavitt. "TUNE IN: Tomorrow night at 9PM ET, President Trump will ...

Every day we experience many desires—we want to watch the next episode, buy another gadget online, or eat the slice of chocolate cake. Is resisting all these desires (or as many as we can) the ...

You have /3 articles left. Sign up for a free account or log in. A Pennsylvania district court judge ordered Tuesday that the University of Pennsylvania must comply ...

Cash-strapped Transportation Security Administration workers at Hartsfield-Jackson Atlanta International Airport who were given $1,000 gift cards by filmmaker Tyler Perry are reportedly being told to ...

Biopharma funding fell 20% last year, reversing the post-pandemic recovery as the IPO haul dropped to the lowest level of the past 10 years. IQVIA shared the data in a report that tracked surges in ...

Things keep lining up against Microsoft , with all roads leading back to the company's tarnished standing as an artificial intelligence leader and how that could impact the company's Azure cloud ...

As tech companies roll out platforms specifically designed for health care consultation, AI is rapidly becoming a key player in many people's medical decisions. According to OpenAI, the maker of ...

Tech industries are losing their strength. One economist said tech job losses outpaced the past two recessions. Still, there is weakness in other areas of the job market. It's a tech bloodbath in the ...

Dim Sum Give Some, the annual food-lover's festival and fundraiser organized by chefs Dan Jacobs and Dan Van Rite of EsterEv and DanDan, is coming back for a seventh year with a record number of ...

Over a year after first agreeing to a reverse merger with Pulmatrix, protein degradation biotech Cullgen has instead opted to be bought by Gyre Therapeutics in a $300 million all-stock acquisition.